Table 3.

Stratified analyses of bone mineral density in respondents, according to age in HBsAg or HCV-RNA seropositivity.

	Hepatitis B and C
	HBsAg (–)	HBsAg (+)	P -value	HCV-RNA (–)	HCV-RNA (+)	P -value
TFB
20–39	0	−0.001 (−0.023, 0.021)	0.90	–	–	–
40–59	0	−0.006 (−0.017, 0.005)	0.28	0	−0.011 (−0.032, 0.010)	0.32
60–70	0	−0.009 (−0.021, 0.003)	0.16	0	−0.012 (−0.043, 0.020)	0.47
FNB
20–39	0	0.002 (−0.020, 0.024)	0.87	0	−0.001 (−0.072, 0.071)	0.99
40–59	0	−0.001 (−0.011, 0.010)	0.87	0	0.011 (−0.010, 0.033)	0.30
60–70	0	−0.007 (−0.019, 0.005)	0.23		−0.015 (−0.046, 0.016)	0.35
TSB
20–39	0	0.004 (−0.017, 0.025)	0.70	0	−0.025 (−0.109, 0.059)	0.56
40–59	0	−0.012 (−0.025, 0.001)	0.07	0	0.005 (−0.026, 0.036)	0.77
60–70	0	−0.020 (−0.037, −0.003)	0.02	0	−0.050 (−0.103, 0.004)	0.07

Adjusted for gender, race, income level, education level, AST, ALT, BMI, smoking, alcohol consumption, calcium intake, HDL, uric acid, creatinine, blood calcium levels, blood glucose, and history of diabetes.